ARSArs Technica·2hHealth
score-0.60
FDA Challenges Tavneos Approval Over Data Concerns, Prompting Patient Access Review
Original
The FDA wants to pull its approval of a drug. It’s not so easy.
“Highlights regulatory failure and data manipulation, framing the delay in withdrawal as a systemic obstacle.”